Bcl-2 and bax expression and prostate cancer outcome in men treated with radiotherapy in Radiation Therapy Oncology Group protocol 86-10.
about
Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate CancerGenomic and Histopathological Tissue Biomarkers That Predict Radiotherapy Response in Localised Prostate CancerBCL2 genotypes and prostate cancer survival.Tissue biomarkers for prostate cancer radiation therapy.Menoprogen, a TCM Herbal Formula for Menopause, Increases Endogenous E2 in an Aged Rat Model of Menopause by Reducing Ovarian Granulosa Cell Apoptosis.Vascular endothelial growth factor (VEGF) expression in locally advanced prostate cancer: secondary analysis of radiation therapy oncology group (RTOG) 8610.Prognostic value of survivin in locally advanced prostate cancer: study based on RTOG 8610.Protein kinase A RI-alpha predicts for prostate cancer outcome: analysis of radiation therapy oncology group trial 86-10.Antisense-MDM2 sensitizes LNCaP prostate cancer cells to androgen deprivation, radiation, and the combination in vivo.Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02.Predictive models in external beam radiotherapy for clinically localized prostate cancer.Prospective Validation of Diagnostic Tumor Biomarkers in Men Treated With Radiotherapy for Prostate Cancer.
P2860
Q26766638-3F4DD0A9-C70F-4B0E-AAFE-45086A2BCB06Q26778586-764D6108-3E3C-4E90-A182-157798E11663Q33708677-B0DC400B-8A87-426B-B4CB-607BA4435E19Q36141341-41924C00-D888-4722-AF37-9F1691F7BA31Q36626276-A3CB21FB-613A-4914-B45C-0BED9F86904FQ36843454-09F434E6-B3E4-40A3-BED6-9C0DDFBCAC37Q37182921-83E99357-D17A-4000-BB25-F8D87C78676CQ37372655-E1FEAAF4-6450-49A2-AEF3-0F7569C280E9Q37389892-B0FFB982-B87B-4075-93D9-1B5E3E39DD8BQ37389895-42F5A782-B469-4507-8BA2-FF3FDAC12452Q37526758-5972D622-079C-44B9-AC9D-1DE0979BD12AQ38375214-FA21A752-EBD3-449D-89DA-12EBCBE2A946
P2860
Bcl-2 and bax expression and prostate cancer outcome in men treated with radiotherapy in Radiation Therapy Oncology Group protocol 86-10.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Bcl-2 and bax expression and p ...... Oncology Group protocol 86-10.
@ast
Bcl-2 and bax expression and p ...... Oncology Group protocol 86-10.
@en
type
label
Bcl-2 and bax expression and p ...... Oncology Group protocol 86-10.
@ast
Bcl-2 and bax expression and p ...... Oncology Group protocol 86-10.
@en
prefLabel
Bcl-2 and bax expression and p ...... Oncology Group protocol 86-10.
@ast
Bcl-2 and bax expression and p ...... Oncology Group protocol 86-10.
@en
P2093
P2860
P1476
Bcl-2 and bax expression and p ...... Oncology Group protocol 86-10.
@en
P2093
Alan Pollack
Howard M Sandler
Li-Yan Khor
M Elizabeth H Hammond
Michelle Desilvio
Miljenko V Pilepich
Paul Okunieff
Timothy J McDonnell
William T Sause
P2860
P356
10.1016/J.IJROBP.2006.03.056
P407
P577
2006-07-11T00:00:00Z